High-density genotyping of immune loci in Kawasaki disease and IVIG treatment response in European-American case-parent trio study

Genes and Immunity

Volumn 15, Issue 8, 2014, Pages 534-542

  Shendre, A ^a   Wiener, H W ^a   Zhi, D ^a   Vazquez, A I ^a   Portman, M A ^b   Shrestha, S ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; CADHERIN 22; FUCOSYLTRANSFERASE; GALACTOSIDE 2 ALPHA LEVO FUCOSYLTRANSFERASE 1; HLA ANTIGEN CLASS 2; HLA DOB ANTIGEN; HLA DQB2 ANTIGEN; IMMUNOGLOBULIN; SPACER DNA; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; GALACTOSIDE 2-ALPHA-L-FUCOSYLTRANSFERASE; SYNTAXIN 1;

3' UNTRANSLATED REGION; ARTICLE; DISEASE PREDISPOSITION; EUROPEAN AMERICAN; GENE; GENE LOCUS; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MUCOCUTANEOUS LYMPH NODE SYNDROME; PARENT; PATHOGENESIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STX1B GENE; TREATMENT RESPONSE; CAUCASIAN; CHILD; ETHNOLOGY; FEMALE; GENETIC PREDISPOSITION; GENETICS; GENOTYPING TECHNIQUE; INFANT; MALE; MULTIVARIATE ANALYSIS; NUCLEAR FAMILY; PRESCHOOL CHILD; PROCEDURES; STATISTICAL MODEL; TREATMENT OUTCOME; UNITED STATES;

3' UNTRANSLATED REGIONS; CHILD; CHILD, PRESCHOOL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FUCOSYLTRANSFERASES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GENOTYPING TECHNIQUES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; INTRONS; LOGISTIC MODELS; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; MULTIVARIATE ANALYSIS; NUCLEAR FAMILY; POLYMORPHISM, SINGLE NUCLEOTIDE; SYNTAXIN 1; TREATMENT OUTCOME; UNITED STATES;

EID: 84927174918     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2014.47     Document Type: Article

References (55)

1. Kawasaki T. [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]. Arerugi 1967; 16: 178-222.
2. DeLisi LE, Mesen A, Rodriguez C, Bertheau A, LaPrade B, Llach M et al. Genomewide scan for linkage to schizophrenia in a Spanish-origin cohort from Costa Rica. Am J Med Genet 2002; 114: 497-508.
3. Huang SK, Lin MT, Chen HC, Huang SC, Wu MH. Epidemiology of Kawasaki disease: prevalence from national database and future trends projection by system dynamics modeling. J Pediatr 2013; 163: 126-31 e1.
4. Holman RC, Christensen KY, Belay ED, Steiner CA, Effler PV, Miyamura J et al. Racial/ethnic differences in the incidence of Kawasaki syndrome among children in Hawaii. Hawaii Med J 2010; 69: 194-197.
5. Bayers S, Shulman ST, Paller AS. Kawasaki disease: part II. Complications and treatment. J Am Acad Dermatol 2013; 69: 513 e1-513 e8.
6. Wang CL, Wu YT, Liu CA, Kuo HC, Yang KD. Kawasaki disease: infection, immunity and genetics. Pediatr Infect Dis J 2005; 24: 998-1004.
7. Uehara R, Yashiro M, Nakamura Y, Yanagawa H. Clinical features of patients with Kawasaki disease whose parents had the same disease. Arch Pediatr Adolesc Med 2004; 158: 1166-1169.
8. Weng KP, Hsieh KS, Ho TY, Huang SH, Lai CR, Chiu YT et al. IL-1B polymorphism in association with initial intravenous immunoglobulin treatment failure in Taiwanese children with Kawasaki disease. Circ J 2010; 74: 544-551.
9. Makowsky R, Wiener HW, Ptacek TS, Silva M, Shendre A, Edberg JC et al. Fc?R gene copy number in Kawasaki disease and intravenous immunoglobulin treatment response. Pharmacogenet Genomics 2013; 23: 455-462.
10. Shrestha S, Wiener HW, Olson AK, Edberg JC, Bowles NE, Patel H et al. Functional FCGR2B gene variants influence intravenous immunoglobulin response in patients with Kawasaki disease. J Allergy Clin Immunol 2011; 128: 677-680.
11. Shrestha S, Wiener HW, Shendre A, Kaslow RA, Wu J, Olson AK et al. Role of activating Fc?R gene polymorphisms in Kawasaki disease susceptibility and intravenous immunoglobulin response. Circ Cardiovasc Genet 2012; 5: 309-316.
12. Portman MA, Wiener HW, Silva M, Shendre A, Shrestha S. DC-SIGN gene promoter variants and IVIG treatment response in Kawasaki disease. Pediatr Rheumatol Online J 2013; 11: 32.
13. Yan Y, Ma Y, Liu Y, Hu H, Shen Y, Zhang S et al. Combined analysis of genomewide-linked susceptibility loci to Kawasaki disease in Han Chinese. Hum Genet 2013; 132: 669-680.
14. Fehrmann RS, Jansen RC, Veldink JH, Westra HJ, Arends D, Bonder MJ et al. Trans-eQTLs reveal that independent genetic variants associated with a complex phenotype converge on intermediate genes, with a major role for the HLA. PLoS Genet 2011; 7: e1002197.
15. Fairfax BP, Makino S, Radhakrishnan J, Plant K, Leslie S, Dilthey A et al. Genetics of gene expression in primary immune cells identifies cell type-specific master regulators and roles of HLA alleles. Nat Genet 2012; 44: 502-510.
16. Kramer U, Illig T, Grune T, Krutmann J, Esser C. Strong associations of psoriasis with antigen processing LMP and transport genes TAP differ by gender and phenotype. Genes Immun 2007; 8: 513-517.
17. Moins-Teisserenc H, Semana G, Alizadeh M, Loiseau P, Bobrynina V, Deschamps I et al. TAP2 gene polymorphism contributes to genetic susceptibility to multiple sclerosis. Hum Immun 1995; 42: 195-202.
18. Singal DP, Ye M, Qiu X, D'Souza M. Polymorphisms in the TAP2 gene and their association with rheumatoid arthritis. Clin Exp Rheumatol 1994; 12: 29-33.
19. Wordsworth BP, Pile KD, Gibson K, Burney RO, Mockridge I, Powis SH. Analysis of the MHC-encoded transporters TAP1 and TAP2 in rheumatoid arthritis: linkage with DR4 accounts for the association with a minor TAP2 allele. Tissue Antigens 1993; 42: 153-155.
20. Wang CL, Wu YT, Liu CA, Lin MW, Lee CJ, Huang LT et al. Expression of CD40 ligand on CD4+ T-cells and platelets correlated to the coronary artery lesion and disease progress in Kawasaki disease. Pediatrics 2003; 111: E140-E147.
21. Zhou J, Li J, Chen J, Liu Y, Gao W, Ding Y. Over-expression of CDH22 is associated with tumor progression in colorectal cancer. Tumour Biol 2009; 30: 130-140.
22. Khor CC, Davila S, Breunis WB, Lee YC, Shimizu C, Wright VJ et al. Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease. Nat Genet 2011; 43: 1241-1246.
23. Onouchi Y. Genetics of Kawasaki disease: what we know and don't know. Circ J 2012; 76: 1581-1586.
24. Kuo HC, Chang WC. Genetic polymorphisms in Kawasaki disease. Acta Pharmacol Sinic 2011; 32: 1193-1198.
25. Zhou H, Yu Y, Li H, Shi W, Yang H, Liu C et al. Anti-H can trigger apoptosis and down-regulate FUT1 expression in erythroid differentiated K562 cells without complement mediation. Transplant Immunol 2012; 27: 151-156.
26. Armistead PM, Mohseni M, Gerwin R, Walsh EC, Iravani M, Chahardouli B et al. Erythroid-lineage-specific engraftment in patients with severe hemoglobinopathy following allogeneic hematopoietic stem cell transplantation. Exp Hematol 2008; 36: 1205-1215.
27. Isozaki T, Ruth JH, Amin MA, Campbell PL, Tsou PS, Ha CM et al. Fucosyltransferase 1 mediates angiogenesis, cell adhesion and rheumatoid arthritis synovial tissue fibroblast proliferation. Arthritis Res Ther 2014; 16: R28.
28. Moehler TM, Sauer S, Witzel M, Andrulis M, Garcia-Vallejo JJ, Grobholz R et al. Involvement of alpha 1-2-fucosyltransferase I (FUT1) and surface-expressed Lewis (y) (CD174) in first endothelial cell-cell contacts during angiogenesis. J Cell Physiol 2008; 215: 27-36.
29. Moore GT, Brown SJ, Winterhalter AC, Lust M, Salvaris EJ, Selan C et al. Glycosylation changes in hFUT1 transgenic mice increase TCR signaling and apoptosis resulting in thymocyte maturation arrest. Mol Immunol 2008; 45: 2401-2410.
30. Zhang Z, Sun P, Liu J, Fu L, Yan J, Liu Y et al. Suppression of FUT1/FUT4 expression by siRNA inhibits tumor growth. Biochim Biophys Acta 2008; 1783: 287-296.
31. Nakamura H, Jasper MJ, Hull ML, Aplin JD, Robertson SA. Macrophages regulate expression of alpha1, 2-fucosyltransferase genes in human endometrial epithelial cells. Mol Hum Reprod 2012; 18: 204-215.
32. Xu K, Chong DC, Rankin SA, Zorn AM, Cleaver O. Rasip1 is required for endothelial cell motility, angiogenesis and vessel formation. Dev Biol 2009; 329: 269-279.
33. Xu K, Sacharidou A, Fu S, Chong DC, Skaug B, Chen ZJ et al. Blood vessel tubulogenesis requires Rasip1 regulation of GTPase signaling. Dev Cell 2011; 20: 526-539.
34. Ikram MK, Sim X, Jensen RA, Cotch MF, Hewitt AW, Ikram MA et al. Four novel Loci (19q13, 6q24, 12q24, and 5q14) influence the microcirculation in vivo. PLoS Genet 2010; 6: e1001184.
35. Franke A, McGovern DP, Barrett JC, Wang K, Radford-Smith GL, Ahmad T et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet 2010; 42: 1118-1125.
36. ENSEMBLBRD7P2 phenotypes. http://useast.ensembl.org/Homo-sapiens/Gene/Summary?db=core;g=ENSG00000184100;r=3:159000000-160700000.
37. Ballester V, Vendrell R, Haritunians T, Klomhaus A, Guo X, McGovern DP et al. Su1761 A Baz1a haplotype with ancient American ancestry contributes to IBD in Puerto Ricans. Gastroenterology 2013; 144: S-470.
38. Sanchez-Molina S, Mortusewicz O, Bieber B, Auer S, Eckey M, Leonhardt H et al. Role for hACF1 in the G2/M damage checkpoint. Nucleic Acids Res 2011; 39: 8445-8456.
39. Uhlenbrock K, Huber J, Ardati A, Busch AE, Kostenis E. Fluid shear stress differentially regulates gpr3, gpr6, and gpr12 expression in human umbilical vein endothelial cells. Cell Physiol Biochem 2003; 13: 75-84.
40. Perricone C, Ciccacci C, Ceccarelli F, Di Fusco D, Spinelli FR, Cipriano E et al. TRAF3IP2 gene and systemic lupus erythematosus: association with disease susceptibility and pericarditis development. Immunogenetics 2013; 65: 703-709.
41. Bennett MK, Calakos N, Scheller RH. Syntaxin: a synaptic protein implicated in docking of synaptic vesicles at presynaptic active zones. Science 1992; 257: 255-259.
42. Smirnova T, Miniou P, Viegas-Pequignot E, Mallet J. Assignment of the human syntaxin 1B gene (STX) to chromosome 16p11.2 by fluorescence in situ hybridization. Genomics 1996; 36: 551-553.
43. Gomez-Jaramillo L, Delgado-Perez L, Reales E, Mora-Lopez F, Mateos RM, Garcia-Poley A et al. Syntaxin-4 is implicated in the secretion of antibodies by human plasma cells. J Leukoc Biol 2014; 95: 305-312.
44. Rahman A, Decourcey J, Larbi NB, Loughran ST, Walls D, Loscher CE. Syntaxin-4 is essential for IgE secretion by plasma cells. Biochem Biophys Res Commun 2013; 440: 163-167.
45. Pennica D, Swanson TA, Shaw KJ, Kuang WJ, Gray CL, Beatty BG et al. Human cardiotrophin-1: protein and gene structure, biological and binding activities, and chromosomal localization. Cytokine 1996; 8: 183-189.
46. Robador PA, Moreno MU, Beloqui O, Varo N, Redon J, Fortuno A et al. Protective effect of the 1742(C/G) polymorphism of human cardiotrophin-1 against left ventricular hypertrophy in essential hypertension. J Hypertens 2010; 28: 2219-2226.
47. Erdmann J, Hassfeld S, Kallisch H, Fleck E, Regitz-Zagrose V. Genetic variants in the promoter (g983G4T) and coding region (A92T) of the human cardiotrophin-1 gene (CTF1) in patients with dilated cardiomyopathy. Hum Mutat 2000; 16: 448.
48. Drobic V, Cunnington RH, Bedosky KM, Raizman JE, Elimban VV, Rattan SG et al. Differential and combined effects of cardiotrophin-1 and TGF-beta1 on cardiac myofibroblast proliferation and contraction. Am J Physiol Heart Circ Physiol 2007; 293: H1053-H1064.
49. Robador PA, San Jose G, Rodriguez C, Guadall A, Moreno MU, Beaumont J et al. HIF-1-mediated up-regulation of cardiotrophin-1 is involved in the survival response of cardiomyocytes to hypoxia. Cardiovasc Res 2011; 92: 247-255.
50. Kumar V, Westra HJ, Karjalainen J, Zhernakova DV, Esko T, Hrdlickova B et al. Human disease-associated genetic variation impacts large intergenic non-coding RNA expression. PLoS Genet 2013; 9: e1003201.
51. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004; 110: 2747-2771.
52. Cortes A, Brown MA. Promise and pitfalls of the Immunochip. Arthritis Res Ther 2011; 13: 101.
53. Parkes M, Cortes A, van Heel DA, Brown MA. Genetic insights into common pathways and complex relationships among immune-mediated diseases. Nat Rev Genet 2013; 14: 661-673.
54. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-575.
55. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006; 38: 904-909.